A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

ClinicalTrials.gov ID: NCT07196644

Public ClinicalTrials.gov record NCT07196644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Evaluate the Safety and Efficacy of Telisotuzumab Adizutecan for the Treatment of Subjects With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification

Study identification

NCT ID: NCT07196644
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: AbbVie; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Solid Tumors Harboring MET Amplification

Interventions

Telisotuzumab Adizutecan Drug

Drug

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2025
Primary completion: Nov 30, 2030
Completion: Nov 30, 2030
Last update posted: Jul 15, 2026

2025 – 2030

United States locations

U.S. sites: 17
U.S. states: 11
U.S. cities: 16

Facility	City	State	ZIP	Site status
Beverly Hills Cancer Center /ID# 275465	Beverly Hills	California	90211	Recruiting
City of Hope National Medical Center /ID# 275613	Duarte	California	91010	Recruiting
Valkyrie Clinical Trials /ID# 275547	Los Angeles	California	90067	Recruiting
Yale University School of Medicine /ID# 275978	New Haven	Connecticut	06510	Recruiting
Florida Cancer Specialists - North /ID# 277137	St. Petersburg	Florida	33705	Recruiting
Northwestern University Feinberg School of Medicine /ID# 276436	Chicago	Illinois	60611-2927	Recruiting
University of Chicago Medical Center /ID# 275342	Chicago	Illinois	60637	Recruiting
START Midwest /ID# 276603	Grand Rapids	Michigan	49546	Recruiting
Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 275999	New York	New York	10065	Recruiting
Duke Cancer Institute /ID# 275604	Durham	North Carolina	27710	Recruiting
SCRI Oncology Partners /ID# 275686	Nashville	Tennessee	37203	Recruiting
Dell Seton Medical Center /ID# 276474	Austin	Texas	78701	Recruiting
UT Southwestern Medical Center /ID# 276053	Dallas	Texas	75390	Recruiting
The University of Texas MD Anderson Cancer Center /ID# 275663	Houston	Texas	77030	Recruiting
South Texas Accelerated Research Therapeutics (START) /ID# 276608	San Antonio	Texas	78229	Recruiting
Start Mountain Region /ID# 276607	West Valley City	Utah	84119	Recruiting
Virginia Cancer Specialists - Fairfax /ID# 276010	Fairfax	Virginia	22031	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07196644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 15, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07196644 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →